Clinical Trials Browser

Leukemia, Myeloid, Acute × tazemetostat × 90 days × Clear all

NCT05627232 2026-03-12

Tazemetostat and Palbociclib With CPX-351for R/R AML

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute